Ilke Panzer appointed new Greiner Bio-One Division Manager

Dec. 7, 2023
Ilke Panzer (57) will succeed Manfred Stanek as CEO of Greiner Bio-One on February 1, 2024.

Ilke Panzer will take over as head of Greiner Bio-One, Greiner’s medical technology division, with effect from February 1, 2024. She succeeds Manfred Stanek, who has been the interim head of the division since September 1, 2023, and who will return in full to his role as Chief Operating Officer (COO) of the holding company Greiner AG after the handover.

Ilke Panzer (57) was born in Germany but pursued her career in the US, where most recently she worked as a freelance healthcare innovation consultant. With management experience at Assurance Laboratories LLC, BloodCenter of Wisconsin, and Johnson & Johnson, she has excellent knowledge of the healthcare and pharmaceutical industries. She began her career at General Electric, with roles including general manager for Global Ultrasound. Panzer holds degrees in Engineering, Computer and Systems Engineering from the University of Connecticut and from the National Technological University in Fort Collins, Colorado. She has been a member of the Supervisory Board at the German pharmaceutical and laboratory equipment supplier Sartorius AG since 2017.

Greiner Bio-One release